VALYSTR · Stock research
Listed on NYSE American. What the market is pricing into AIM ImmunoTech Inc. (AIM) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $4.9M · revenue $95,000 (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows